Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.

Background: Women who live in rural and urban settings have different outcomes for breast cancer. A 21-gene assay predicts 10-year distant recurrence risk and potential benefit of chemotherapy for women with hormone receptor-positive (HR+) breast cancer.

Objective: To assess differences in scores and cancer therapies received by rural versus urban residence.

Evaluating primary care providers' views on survivorship care plans generated by an electronic health record system.

Purpose: Survivorship care plans for cancer survivors may facilitate provider-to-provider communication. Primary care provider (PCP) perspectives on care plan provision and use are limited, especially when care plans are generated by an electronic health record (EHR) system. We sought to examine PCPs' perspectives regarding EHR-generated care plans.